BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Jiangbo Pharmaceuticals, Inc. (Formerly known as Genesis Pharmaceuticals Enterprises, Inc.) Reports Outcome of Annual Meeting of Stockholders


6/30/2011 6:58:35 AM

LAIYANG, China, June 30, 2011 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc. (Nasdaq: JGBO) ("Jiangbo" or the "Company"), a pharmaceutical company with its principal operations in the People's Republic of China ("China"), today announced that it held its 2011 Annual Meeting of Stockholders (the ''Annual Meeting'') on June 28, 2011 in Laiyang City, Shandong Province, PRC.

At the Annual Meeting, the Company's stockholders were asked to vote on a proposal to elect five directors to serve until the Company's 2012 Annual Meeting of Stockholders and until their successors are duly elected and qualified. Mr. Wubo Cao, Mr. Xiaowei Feng, Ms. Lei Huang, Mr. Jian Ge and Mr. George Zhou were elected as members of the Board of Directors of the Company at the Annual Meeting.

The stockholders also ratified the appointment of Marcum Bernstein & Pinchuk LLP as the Company's independent registered public accountants for the fiscal year ending June 30, 2011 at the Annual Meeting.

At the Annual Meeting, the Company's stockholders also approved and adopted the Jiangbo Pharmaceuticals, Inc. 2011 Omnibus Securities and Incentive Plan.

About Jiangbo Pharmaceuticals, Inc.

Jiangbo is engaged in the research, development, production, marketing and sales of pharmaceutical products in China. The Company's operations are located in Eastern China in an Economic Development Zone in Laiyang City, Shandong Province. Jiangbo produces both western and Chinese herbal-based medical drugs in tablet, capsule, granule, syrup and electuary (sticky syrup) form. For additional information, please visit the Company's website (www.jiangbopharma.com).

Contact:

Jiangbo Pharmaceuticals, Inc.

Mr. Jin Linxian,CEO

Phone: +86-535-728-2397

Email: jinlinxian@jiangbo.com

Web: http://www.jiangbopharma.com



SOURCE Jiangbo Pharmaceuticals, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES